KLARON Drug Patent Profile
✉ Email this page to a colleague
When do Klaron patents expire, and what generic alternatives are available?
Klaron is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in KLARON is sulfacetamide sodium. There are three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klaron
A generic version of KLARON was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
Summary for KLARON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Patent Applications: | 4,139 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for KLARON |
What excipients (inactive ingredients) are in KLARON? | KLARON excipients list |
DailyMed Link: | KLARON at DailyMed |
Pharmacology for KLARON
Drug Class | Sulfonamide Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for KLARON
US Patents and Regulatory Information for KLARON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | KLARON | sulfacetamide sodium | LOTION;TOPICAL | 019931-001 | Dec 23, 1996 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |